Unlisted hospital software technology company Vitro Software is aiming for a re-rating of its revenue results, based on strong adoption from the Australian market, according to CEO Declan Daly.
Vitro Software has developed technology which enables organisations, particularly hospitals, to move from paper-based forms and processes to electronic-based, while maintaining the original look and feel of the documents.
Speaking at the TechKnow Invest Roadshow, Mr Daly said that the adoption of its technology has been particularly strong in Australia.
“We have a very large cohort of clients that we implemented in 2016-17 and are live and operational now. And we’re looking at really launching in 2018 using that base of really good referenceable clients to hopefully go into the next sphere – particularly in Australia.
We’re looking at developing the platform globally, but with a focus on Australia… We are in Australia in a big way,” he said.
Mr Daly added that approximately 70 percent of the company’s revenue is Australian, boasting major clients in the Asia-Pacific region, including private healthcare provider Bendigo Health, security giant Serco and the Chris O’Brien Lifehouse at Royal Prince Alfred Hospital in Sydney.
Vitro Software is considering an IPO on the ASX in the future and already has a global presence with its technology used throughout Europe, as well as in Africa and the Middle East.
The second instalment of the TechKnow Invest Roadshow will be held at the Grand Hyatt Hotel in Melbourne on Thursday 12 April, to find out more or register please go to: https://www.techknowinvestroadshow.com.au/
